✦ LIBER ✦

The broad spectrum of unstable angina pectoris and its implications for future controlled trials

✍ Scribed by Jane-Iris Farhi; Marc Cohen; Valentin Fuster

Book ID: 115672257
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 551 KB
Volume: 58
Category: Article
ISSN: 0002-9149
DOI: 10.1016/0002-9149(86)90031-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trials of unfractionated hepari

Clinical trials of unfractionated heparin and low-molecular-weight heparin in addition to aspirin for the treatment of unstable angina pectoris: do the results apply to all patients?

✍ Craig R Walsh; Donald M Lloyd-Jones; Carlos A Camargo Jr.; Robert P Giugliano; C 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Comparison of verapamil and propranolol

Comparison of verapamil and propranolol therapy for angina pectoris at rest: A randomized, multiple-crossover, controlled trial in the coronary care unit

✍ Oberdan Parodi; Ignazio Simonetti; Claudio Michelassi; Clara Carpeggiani; Andrea 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 960 KB

Outcome of percutaneous coronary interve

Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry)

✍ Steven P Sedlis; Kodangudi B Ramanathan; Douglass A Morrison; Gulshan Sethi; Jer 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Response-guided peg-interferon plus riba

Response-guided peg-interferon plus ribavirin treatment duration in chronic hepatitis C: Meta-analyses of randomized, controlled trials and implications for the future

✍ Vincent Di Martino; Carine Richou; Jean-Paul Cervoni; Jose M. Sanchez-Tapias; Do 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 333 KB 👁 1 views

Response-guided pegylated interferon (peg-IFN) plus ribavirin (P/R) therapy trials on genotype (G)1 and G2/G3 hepatitis C virus-infected patients provide contradictory results. We conducted meta-analyses of randomized, controlled trials to address (1) the benefit of a 72-week extended-duration thera